Volume 20, Issue 4 , Pages 665-679, December 2006
Pathophysiology of insulin resistance
Insulin resistance is a feature of a number of clinical disorders, including type 2 diabetes/glucose intolerance, obesity, dyslipidaemia and hypertension clustering in the so-called metabolic syndrome. Insulin resistance in skeletal muscle manifests itself primarily as a reduction in insulin-stimulated glycogen synthesis due to reduced glucose transport. Ectopic lipid accumulation plays an important role in inducing insulin resistance. Multiple defects in insulin signalling are responsible for impaired glucose metabolism in target tissues of subjects with features of insulin resistance. Inflammatory molecules and lipid metabolites inhibit insulin signalling by stimulating a number of different serine kinases which are responsible for serine phosphorylation of Insulin Receptor Substrate-1 (IRS-1).
Key words: insulin resistance, insulin signalling, glucose transport
To access this article, please choose from the options below
PII: S1521-690X(06)00078-9
doi:10.1016/j.beem.2006.09.007
© 2006 Elsevier Ltd. All rights reserved.
Volume 20, Issue 4 , Pages 665-679, December 2006
